Evidence map›Paper›PMID 19398011›Full record

ReviewMethods (San Diego, Calif.)2009

The L1 retrotransposition assay: a retrospective and toolkit.

Sanjida H Rangwala, Haig H Kazazian

Abstract readReview
In one paragraph

Review in Methods (San Diego, Calif.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. LINE-1 Retrotransposition Assays in Embryonic Stem Cells.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  9. Article
  10. Review
  11. sRNA/L1 retrotransposition: using siRNAs and miRNAs to expand the applications of the cell culture-based LINE-1 retrotransposition assay.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. LINE-1 Cultured Cell Retrotransposition Assay.Methods in molecular biology (Clifton, N.J.) · 2016
    Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sanjida H RangwalaDepartment of Genetics, University of Pennsylvania School of Medicine, 564 Clinical Research Building, 415 Curie Boulevard, Philadelphia, PA 19104, USA.
Haig H Kazazian

Funding

HUMAN TRANSPOSABLE ELEMENTR01GM045398 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI KAZAZIAN, HAIG H. · 1991 to 2010
$4.7M
Retrotransposition in Health and DiseaseR01GM099875 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI KAZAZIAN, HAIG H. · 2012 to 2019
$4.0M
NIGMS NIH HHS R01 GM045398NIGMS NIH HHS R01 GM099875
6 · The paper itself

Abstract

LINE1s (L1s) are a class of mammalian non-LTR (long terminal repeat) retroelements that make up nearly 20% of the human genome. Because of the difficulty of studying the mobilization of endogenous L1s, an exogenous cell culture retrotransposition assay has become integral to research in L1 biology. This assay has allowed for investigation of the mechanism and consequences of mobilization of this retroelement, both in cell lines and in whole animal models. In this paper, we outline the genesis of in vitro retrotransposition systems which led to the development of the L1 retrotransposition assay in the mid-1990s. We then provide a retrospective, describing the many uses and variations of this assay, ending with caveats and predictions for future developments. Finally, we provide detailed protocols on the application of the retrotransposition assay, including lists of constructs available in the L1 research community and cell lines in which this assay has been applied.

Indexed as

AnimalsCell Culture TechniquesCell LineChickensCricetinaeGenetic TechniquesHumansLong Interspersed Nucleotide ElementsMiceModels, GeneticMutagenesis, InsertionalRats

Identifiers

PMID19398011
PMCPMC2763987

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.